rediff.com
REAL-TIME QUOTE
Enter Company or MF
e.g. Tata motors, Reliance MF, 500570
AstraZeneca Pharma India Ltd. - Research Center
506820 ASTRAZEN Group (A) BSE data
Add to watchlist
 
Back to Company Page
Results
Statement
More
Annual results in brief
(Rs crore)
Mar ' 20 Mar ' 19 Mar ' 18 Mar ' 17 Mar ' 16
Sales 831.81 728.29 571.00 539.57 563.73
Operating profit 120.69 71.30 46.29 29.39 16.42
Interest 1.14 - - - -
Gross profit 132.54 87.59 58.54 49.03 23.19
EPS (Rs) 28.88 21.78 10.37 9.78 2.10
Annual  results in details
Mar ' 20 Mar ' 19 Mar ' 18 Mar ' 17 Mar ' 16
Other income 12.99 16.29 12.25 19.64 6.77
Stock adjustment -39.21 -1.38 -51.00 17.51 5.42
Raw material 70.21 62.67 27.88 14.00 34.76
Power and fuel - - - - -
Employee expenses 216.70 197.40 153.53 163.48 169.35
Excise - - - - -
Admin and selling expenses 55.76 79.80 72.81 - -
Research and development expenses - - - - -
Expenses capitalised - - - - -
Other expenses 407.66 318.50 321.49 315.19 337.80
Provisions made - - - - -
Depreciation 18.58 14.92 14.74 15.83 17.43
Taxation 41.75 18.22 17.89 8.76 0.50
Net profit / loss 72.21 54.44 25.91 24.44 5.26
Extra ordinary item - - - - -
Prior year adjustments - - - - -
Equity capital 5.00 5.00 5.00 5.00 5.00
Equity dividend rate - - - - -
Agg.of non-prom. shares (Lacs) - - - - -
Agg.of non promotoholding (%) - - - - -
OPM (%) 14.51 9.79 8.11 5.45 2.91
GPM (%) 15.69 11.76 10.04 8.77 4.06
NPM (%) 8.55 7.31 4.44 4.37 0.92

Mutual Fund Selector

Find the fund that is right for you
Close
Add AstraZeneca Pharma India Ltd. to your Portfolio
 
 
 
*Portfolio will be calculated based on BSE values
Close
Add AstraZeneca Pharma India Ltd. to your Watchlist
Alert me if price...
*Watchlist will be based on BSE values
Close